background neutron therapy beneficial patients tumor types resistant photons relatively sensitive radiation work potential therapeutic gain clinical neutron beam evaluated quantifying variations radiosensitivity different cell lines neutrons photons material methods different cell lines exposed vitro neutrons 60co micronuclei frequencies binucleated cells surviving fractions determined cell type results following exposure NUMBER NUMBER gy neutrons micronuclei frequencies significantly correlated observed NUMBER gy photons weak significant correlation variation neutron rbe values determined survival curve inactivation parameters mean inactivation doses photon exposures established conclusion concluded neutron photon sensitivities related use high energy neutron source constitute potential therapeutic gain tumor types identified resistant photons considering definitive oxygen gain factor established neutron beam observed therapeutic gain expected enhanced tumors hypoxia protects cells conventional radiation damage high let gamma rays p66